Medtronic cardiovascular growth in Q2: Will Medtronic plc report Above 8% cardiovascular organic revenue growth in Q2 2027?

96%Above 8%

0 ptsover 24h

The field · 8 outcomes

24h volume$0

Total volume$252

Liquidity—

Open interest$226

Markets11 venue, 0 priced

ResolvesMar 31, 2027in 5 months

First seenSep 9, 2026

Watching0

Probability history

Market-implied probabilities on Kalshi · All recorded history

Open the market

Drag to move · pinch or ⌘/Ctrl+scroll to zoom

Based on market prices from Kalshi. These may differ from Predxy’s combined probability above.

If you’re right

What a stake pays at each venue, before fees

Stake

Side

Venue	Price	Shares	Pays	Profit
	98¢	102	$102	+$2.04 1×

Every share pays $1 if the side wins and nothing if it loses. Venue fees, and the price moving under a large order, are not included. * Last traded price, not a live quote. Not financial advice.

Where this question trades

1 venue

Comparable, not identical. Each venue words the question and its resolution rules its own way: settlement date, source of truth, and edge cases can all differ. Read each venue's rules before treating two prices as the same thing.

Medtronic cardiovascular growth in Q2: Will Medtronic plc report Above 8% cardiovascular organic revenue growth in Q2 2027?
96% Above 8%$0 24h volume
Resolution rules
Set your country to see where you can trade.Set your country

Search

Medtronic cardiovascular growth in Q2: Will Medtronic plc report Above 8% cardiovascular organic revenue growth in Q2 2027?

Probability history

If you’re right

Where this question trades

More in Markets

Probability history

If you’re right

Where this question trades

More in Markets